ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1796

Osteoporosis and Vertebral Fractures in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis

Mario García-Carrasco1,2, Pamela Soto-Santillan3, Samanda Adriana Rojas villarraga4, Nicolás Molano-González5 and Claudia Mendoza Pinto6, 1Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR Instituto Mexicano del Seguro Social, Puebla, Mexico, 2Inmunología y Reumatología, Universidad Autónoma de Puebla, Puebla, Mexico, 3Internal Medicine, Systemic Autoimmune Diseases Research Unit, IMSS, Puebla, México, Puebla, Mexico, 4Novartis de Colombia, Bogota, Colombia, 5Center for Autoimmune Diseases Research (CREA). School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia., Bogota, Colombia, 6Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR, IMSS, Puebla, Mexico

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: fractures, meta-analysis, osteoporosis and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density (BMD) and vertebral fractures (FV) in patients with systemic lupus erythematosus (SLE). The aim of this meta-analysis was to evaluate the relationship of SLE and BMD, osteoporosis and vertebral fracture risk.

Methods: A systematic review and meta-regression analysis were performed following the Preferred Reporting Items for Systematic Meta- Analyses (PRISMA) guidelines. Articles were identified from electronic databases (PubMed, Embase, VHL, SciELO and the Cochrane Library). The search was conducted using MesH terms, Boolean operators and keywords, which included “systemic lupus erythematosus”, “osteoporosis”, “bone mineral density” and “vertebral fractures”. Prospective longitudinal and cross-sectional studies were considered for review without language restrictions. Articles were screened for suitability and those selected were evaluated by two investigators who extracted information on study characteristics, outcomes of interest, risk of bias and summarized strength of evidence. Data was extracted where studies met inclusion criteria and were of sufficient quality. BMD reported as the mean ± standard deviation evaluated by dual-energy X-ray absorptiometry (DXA) was analyzed including information of SLE cases and controls, treatment, menopausal status and fractures through a meta-regression analysis adjusted by anatomical region. Data were analyzed using the Metafor package in R (3.0.2 version).

Results: In total 54 articles were identified and analyzed (12593 SLE cases/six anatomical regions and 14235 controls/six anatomical regions). SLE women had less BMD than healthy controls (p< 0,0001), however, in SLE men this difference was absent when they were compared to controls. When only SLE patients were analyzed, the BMD measurements were not statistically different between those with a background of corticosteroid (CTS) therapy and those without CTS therapy. Not surprisingly, postmenopausal SLE patients had lower BMD (lumbar spine and total hip) compared to premenopausal patients (p< 0,0001). The BMD was not different between patients with and without fractures.

Conclusion: This systematic review and meta-regression depicts that women with SLE had higher risk of low BMD than healthy controls. These data did not show that CTS therapy had an impact on BMD.


Disclosure: M. García-Carrasco, None; P. Soto-Santillan, None; S. A. Rojas villarraga, None; N. Molano-González, None; C. Mendoza Pinto, None.

To cite this abstract in AMA style:

García-Carrasco M, Soto-Santillan P, Rojas villarraga SA, Molano-González N, Mendoza Pinto C. Osteoporosis and Vertebral Fractures in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/osteoporosis-and-vertebral-fractures-in-patients-with-systemic-lupus-erythematosus-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/osteoporosis-and-vertebral-fractures-in-patients-with-systemic-lupus-erythematosus-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology